Stockreport

Nkarta Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

Nkarta, Inc.  (NKTX) 
PDF Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full year 20232022 year-end cash and cash equivalents of $354.9 millionCash runway anticipated t [Read more]